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Introduction c10orf76 forms a direct, high affinity complex with PI4KB 131
c10orf76 was previously identified as a putative PI4KB-binding partner through 132 immunoprecipitation experiments [17, 27] , however, it was not clear if this was through a direct 133 interaction. To identify a potential direct interaction between PI4KB and c10orf76 in vitro, we 134 purified recombinant full-length proteins using a baculovirus and Spodoptera frugiperda (Sf9) 135 expression system. Experiments on PI4KB used the slightly smaller isoform 2 variant (1-801, 136 uniprot: Q9UBF8-2), compared to PI4KB isoform 1 (1-816 uniprot: Q9UBF8-1), similar to 137 previous structural studies [14] . His-pulldown assays using NiNTA-agarose beads and purified 138 recombinant proteins showed a direct interaction between PI4KB and His-tagged c10orf76 139 (Fig. 1A) . Pulldown experiments carried out with the PI4KB-binding partners Rab11 and 140 ACBD3 revealed that c10orf76 could form PI4KB-containing ternary complexes with both 141 (Fig. S1) , indicating a unique c10orf76 binding interface on PI4KB compared to Rab11 and 142 ACBD3. To examine the stoichiometry of the c10orf76-PI4KB complex, we subjected apo 143 c10orf76 and c10orf76 with PI4KB to size exclusion chromatography. Apo c10orf76 (79 kDa) 144 eluted from the size exclusion column at a volume consistent with a monomer, while the 145 c10orf76-PI4KB complex eluted at a volume consistent with a 1:1 complex (Fig. 1B) . Since 146 cellular knockout of c10orf76 has been shown to reduce PI4P levels in vivo [28] , we 147 investigated the effect of c10orf76 on PI4KB lipid kinase activity with biochemical membrane 148 reconstitution assays using phosphatidylinositol (PI) vesicles. Intriguingly, c10orf76 was a 149 potent inhibitor of PI4KB, with inhibition being dose-dependent and possessing an IC50 of ~90 150 nM (Fig. 1C) . This inhibitory effect was observed on both pure phosphatidylinositol (PI) 151 vesicles, and vesicles that mimic the composition of the Golgi (20% PI, 10% PS, 45% PE, 25% 152 PC) (Fig. 1D) . This paradoxical PI4KB-inhibitory result in vitro conflicts with observed Golgi 153 PI4P decreases in c10orf76 deficient cells [28] . This suggests that biochemical assays may not 154 fully recapitulate the environment of the Golgi. To further define the role of this complex we 155 focused on defining the molecular basis of this interface, allowing for generation of binding-156 deficient mutants for downstream cellular and viral experiments. 157
158

HDX-MS reveals that PI4KB and c10orf76 form an extended interface involving a 159
disorder-to-order transition of the PI4KB N-lobe linker 160
To identify the putative interface between PI4KB and c10orf76, we employed 161 hydrogen-deuterium exchange mass spectrometry (HDX-MS) to map regions protected in both 162 proteins upon complex formation. HDX-MS is an analytical technique that measures the 163 exchange rate of amide hydrogens in proteins. Because one of the main determinants for amide 164 for both phosphorylated and non-phosphorylated PI4KB. The phosphorylated form had a 3-232 fold increase in the IC50 value, suggesting that Ser496 phosphorylation decreases c10orf76 233 binding affinity, with no shift in the IC50 value for the S496A PI4KB mutant (Fig. 2C) . Kinase 234 assays carried out on both Ser496 phosphorylated PI4KB and non-phosphorylated PI4KB 235
showed that there is no direct effect of the phosphorylation events on basal lipid kinase activity 236 (Fig. 2D) . PKA-mediated phosphorylation-dependent changes in the affinity of protein-protein 237 complexes have been previously described [41, 42] . We utilized HDX-MS to test if the altered 238 inhibition profile we saw was due to decreased affinity between c10orf76 and PI4KB. These 239 experiments were carried out at a single time point of D2O exposure (5 seconds at 20°C) with 240 differing levels of c10orf76 present. Plotting the difference in deuterium incorporation versus 241 c10orf76 concentration gives a characteristic binding isotherm for both phosphorylated and 242 non-phosphorylated PI4KB; displaying a ~3-fold decreased affinity for the phosphorylated 243 form of PI4KB (85 nM vs 30 nM, Fig. S3 ) Phosphomimic variants of Ser496 in PI4KB mutants 244 did not alter the affinity for c10orf76, so they could not be utilized to study this effect in vivo 245 (data not shown). To better characterize the role of the c10orf76-PI4KB complex in vivo, we 246 sought to generate c10orf76-PI4KB complex-disrupting mutations. 247
248
Rationally engineered PI4KB and c10orf76 mutants that disrupt complex formation 249
The c10orf76 binding site within the N-lobe kinase linker of PI4KB identified by HDX-250 MS is highly conserved in vertebrates, with much of the region also conserved in D. 251 melanogaster, but not in C. elegans ( Fig. 2A) . We used a combination of both the sequence 252 conservation and HDX-MS results to design a complex-disrupting mutant. The RL residues at 253 494-495 were mutated to EA (RL494EA), effectively causing both a charge reversal and 254 decrease in hydrophobicity. The RL494EA mutant disrupted binding to His-tagged c10orf76 255 bait in a His pulldown assay (Fig. 2E) and prevented inhibition by c10orf76 in kinase assays 256 (Fig. 2F) . This mutant had exactly the same basal kinase activity as the WT PI4KB on both PI 257 vesicles and Golgi-mimetic vesicles (Fig. 2G) , strongly suggesting that the mutant kinase is 258 properly folded. In an attempt to design rational mutations of c10orf76 that also disrupted 259 binding to PI4KB, multiple mutations were tested in regions 403-408, 534-547 and 632-641 260 that were identified using HDX-MS. Combining the HDX-MS data and sequence homology, 261
we designed a triple alanine mutant at the end of a putative helix (QYANAFL) that was well 262 conserved in vertebrates (Fig. 2J) , close to the HDX-MS protection (FLH residues 409-411 to 263 AAA, referred to as FLH mutant afterwards). The FLH mutant expressed well, significantly 264 reduced binding to PI4KB in a His-pulldown assay (Fig. 2E) , and also showed a marked 265 reduction in its ability to inhibit PI4KB activity (Fig. 2I) . To confirm the c10orf76 FLH mutant 266 does not affect global protein structure, we compared deuterium incorporation of the c10orf76 267 wild-type and FLH mutant and observed no changes in deuterium incorporation seen outside 268 of the predicted helix containing the FLH residues (Fig. S4) . The engineering of complex-269 disrupting mutants that do not alter catalytic activity or protein folding provided an excellent 270 tool to test the importance of the c10orf76-PI4KB complex in cells. 271
272
PI4KB recruits c10orf76 to the Golgi 273
To define the role of the c10orf76-PI4KB interface in cellular localization we utilized 274 fluorescently-tagged variants of the wild-type and complex-disrupting mutants of both PI4KB 275 and c10orf76. Fluorescence microscopy of HEK293 cells expressing GFP-tagged wild-type 276 PI4KB revealed that it primarily localizes to the Golgi (Fig. 3A) . GFP-PI4KB RL494EA, 277 which is deficient in c10orf76 binding, also localized mainly to the Golgi, which suggests that 278 c10orf76 plays a minimal role in the Golgi recruitment of PI4KB (Fig. 3A) . The wild-type 279 GFP-c10orf76 also localizes to the Golgi. However, the PI4KB binding-deficient FLH mutant 280 is redistributed to the cytosol; revealing an important role for PI4KB in the proper cellular 281 localization of c10orf76 (Fig. 3B) . To further analyze the role of PI4KB in the recruitment of 282 c10orf76, we utilized a chemically-inducible protein heterodimerization system that relies on 283 the selective interaction of the FKBP12 (FK506 binding protein 12) and FRB (a 9 kDa fragment 284 of mTOR that binds rapamycin) modules upon treatment with rapamycin [12, 43] . Specifically, 285
we fused the FRB domain to residues 34-63 of a CFP-tagged mitochondrial localization signal 286 from mitochondrial A-kinase anchor protein 1 (AKAP1), and fused mRFP-FKBP12 onto the 287 wild-type or mutant variants of human PI4KB (Fig. 3C) . These constructs allowed us to 288 examine the localization of the wild-type or mutant GFP-c10orf76 following the acute 289 sequestration of PI4KB to the outer mitochondrial membrane, where other Golgi-associating 290 proteins are not be present. Treatment with rapamycin (100 nM) caused the rapid recruitment 291 of mRFP-FKBP12-PI4KB to the mitochondria, which also caused the rapid co-recruitment of 292 c10orf76 ( Fig. 3D; Video 1) ; suggesting that PI4KB is the only component necessary for 293 membrane recruitment of c10orf76. Experiments using mRFP-FKBP12 PI4KB RL494EA 294
showed that although the mutant kinase is relocated to the mitochondria, GFP-c10orf76 does 295 not co-localize ( Fig. 3E; Fig. 3F, Video 2) . Taken together, these live-cell studies corroborated 296 the protein interaction studies completed in vitro and also demonstrate that the newly defined 297 c10orf76-PI4KB interface is required for proper localization of c10orf76 to the Golgi. 298
Compellingly, these findings reveal a potential novel function of PI4KB in the recruitment of 299 c10orf76. 300 301 c10orf76 regulates Arf1 activation and maintains Golgi PI4P levels 302
The paradoxical finding that the loss of c10orf76 leads to increased PI4P levels in cells, 303 yet decreased catalytic activity of PI4KB in vitro, suggested that there was an unknown lipid 304 or protein constituent in cells that is not present in our in vitro experiments. To determine the 305 role of c10orf76 in cells we examined the distribution of different Golgi-localized signaling 306 components in c10orf76-deficient (knockout) HAP1 cells. In agreement with previous studies 307
[28], we found that there were decreased PI4P levels at the Golgi in c10orf76 knockout cells, 308 as indicated by decreased Golgi staining by an anti-PI4P antibody (Fig. 4A) . Intriguingly, there 309 was an apparent increase in Golgi localized PI4KB in the c10orf76 knockout cells (Fig. 4A) , 310 similar to what occurs upon treatment with a PI4KB inhibitor [44] , clearly indicating that 311 decreased PI4P production was not due to loss of PI4KB recruitment in the absence of 312 c10orf76. We tested the localization of different Golgi markers to verify that decreased PI4P 313
was not due to disruption of Golgi morphology. Markers for the cis Golgi (GM130), cis/medial 314 Golgi (Giantin), and the trans-Golgi network (TGN46) all showed similar localization in both 315
WT and c10orf76 knockout cells (Fig. 4B) . The distribution of the ER-Golgi intermediate 316 compartment marker ERGIC53 was also similar, suggesting that Golgi morphology was 317 maintained in the c10orf76 knockout HAP1 cells (Fig. 4B) . 318
We next tested the localization of the Arf1-GEF GBF1, as active GTP-bound Arf1 is a 319 putative activator of PI4KB [21] . In c10orf76 knockout cells there was a redistribution of 320 GBF1, with GBF1 being more diffuse, with less localized at the Golgi (Fig. 4C) . The 321 generation of active GTP-bound Arf1 by Arf-GEFs leads to recruitment of multiple effector 322 proteins, with one of most well characterised being the coatomer proteins, which form COPI 323 coated vesicles that mediate Golgi to ER trafficking. Antibody staining with the CM1 antibody, 324 which only recognizes the native form of coatomer, showed similar Golgi distribution for both 325 WT and c10orf76 knockout cells. However, antibodies recognizing COP-β and -α/γ subunits, 326 which associate with GTP-bound Arf1, not only showed staining in the Golgi, but also diffuse 327 staining in the cytosol in c10orf76 knockout cells which was not observed in wild type cells 328 (Fig. 4C) . Together, these results suggest that c10orf76 plays a key role in Arf1 activation, 329 likely providing a mechanism for increased PI4P levels driven by c10orf76. 330
Replication of c10orf76-dependent enteroviruses requires intact c10orf76-PI4KB 332 interaction 333
All enteroviruses depend on PI4KB kinase activity for replication. Despite the physical 334 and functional connection between PI4KB and c10orf76, enteroviruses showed different 335 dependencies on c10orf76 [28] . Specifically, while Coxsackievirus A10 (CVA10) replication 336 was impaired in c10orf76 knockout cells, the replication of CVB1 was not. Furthermore, 337 c10orf76 was identified as a pro-viral factor for replication of poliovirus (PV1) [45] . We set 338 out to investigate the importance of the c10orf76-PI4KB interaction for replication of CVA10 339 and PV1. We first made a side-by-side comparison of virus replication in HAP1 wildtype and 340 c10orf76 knockout cells in a single cycle of replication. The replication of CVA10 was 341 significantly impaired in c10orf76 deficient cells, with partial inhibition of PV1 replication, 342
and no impairment for replication of CVB3 (Fig. 5A) . Due to the notoriously difficult nature 343 of transfecting HAP1 cells, we determined the importance of the c10orf76-PI4KB interaction 344 for virus replication in HeLa PI4KB knockout cells transfected with different PI4KB 345 expression plasmids as previously described [29] . Expression of wild type PI4KB efficiently 346 restored the replication of all viruses (Fig. 5B) . Expression of the PI4KB RL494EA mutant 347 that is deficient in binding c10orf76 fully rescued replication in CVB3, only partially rescued 348 PV1 replication, and failed to rescue CVA10 replication. These observations suggest that the 349 c10orf76-PI4KB interaction is necessary for CVA10, and to a lesser extent, PV1 replication 350 and thereby implies that functions of c10orf76 are selectively hijacked by specific viruses. 351
352
Discussion
353
Defining the full complement of cellular roles for PI4KB is an important objective in 354 characterizing the integrated control of secretion and membrane trafficking at the Golgi, and 355 also provides a framework for understanding how PI4P can be manipulated by viruses. We 356 have identified the c10orf76-PI4KB interaction as an important Golgi signaling complex and 357 a critical factor in the replication of specific enteroviruses. mediates binding to 14-3-3 proteins, with this leading to an increase in PI4KB activity [22, 23] , 367 that has been suggested to correspond with an increase in PI4KB stability [24] . The most well 368 validated protein binding partner that regulates Golgi recruitment of PI4KB is ACBD3 369 (previously referred to as GCP60) [13] . ACBD3 forms a direct, high-affinity interface with 370 PI4KB that is mediated by a disorder-to-order transition in the N-terminus of PI4KB upon 371 binding to the Q domain of ACBD3 [11, 12] . The recruitment of PI4KB to the Golgi by ACBD3 372 is controlled through the direct interaction of the GOLD domain of ACBD3 with the Golgi 373 resident transmembrane protein Giantin [51] . In addition to regulatory protein interactions, 374 PI4KB is predicted to contain an ALPS motif at the C-terminus that mediates lipid binding to 375 unsaturated membranes [9] . PI4KB plays key non-catalytic roles through its interaction with 376 the GTPase Rab11, with PI4KB required for localizing a pool of Rab11 to the Golgi and TGN 377
[52]. This interaction is mediated through a non-canonical, nucleotide-independent binding 378 interface with the helical domain of PI4KB [14] . However, there are still many unexplained 379 aspects of PI4KB recruitment and regulation, highlighted by the increased recruitment of 380 PI4KB to the Golgi following treatment with PI4KB inhibitors that is concomitant with a 381 decrease in Golgi PI4P levels [44] . 382
The protein c10orf76 was originally identified as a putative PI4KB interacting partner 383 through co-immunoprecipitation experiments using tagged PI4KB [17, 27] . Tests of genetic 384 essentiality identified c10orf76 as a central molecular hub at the Golgi, with it being 385 synthetically lethal in combination with the loss of several different Golgi-signaling proteins, 386 and also showing a genetic link to PI4KB [28] . That study also found that c10orf76 is essential 387 in the KBM7 CML cell line, but not in HAP1 cells, with this relationship also being true for 388 PI4KB. Additional evidence on the essentiality of this protein is highlighted by the 389 homozygous mutant of ARMH3, the mouse homolog of c10orf76, which is lethal at the pre-390 weaning stage [53] . c10orf76 is highly conserved in vertebrates and we find a strong correlation 391 between the conservation of the kinase linker region of PI4KB and the PI4KB-binding site in 392 c10orf76, suggesting that a key role of c10orf76 is linked to its ability to form a complex with 393 PI4KB. PI4KB recruitment to the Golgi is not mediated by c10orf76, but instead it appears that 394 PI4KB is responsible for the Golgi-recruitment of c10orf76. In vitro, c10orf76 led to decreased 395 lipid kinase activity of PI4KB. However, knockout of c10orf76 in cells led to reduced PI4P 396 levels. This discrepancy could be due to the lack of other interacting partners in vitro, such as 397 Arf1/GBF1. c10orf76 knockout led to an increased cytosolic fraction of Arf1 effectors and the 398 Arf GEF GBF1 . Our work reveals c10orf76 as a novel player in Arf1 regulation, with c10orf76 399 required for maintaining active Arf1 and corresponding Golgi PI4P levels. and recruits as well as activates PI4KB [11, 13, 18, 29, 31] . The N-terminal part of the 3A 408
proteins from several enteroviruses (e.g., poliovirus and coxsackie virus B3) directly binds and 409 recruits GBF1, but this interaction is less conserved, severely reduced, or even absent in the 410 3A proteins of rhinoviruses due to subtle amino acid differences in their N-terminus [18, 33] . 411
We find that c10orf76 is required for replication of coxsackie virus A10 and, to a lesser extent, 412 poliovirus and that c10orf76-dependent viruses rely on the c10orf76-PI4KB interface. 
Materials and Methods
437
Protein expression and purification 438 c10orf76 and PI4KB 439
The human C10orf76 gene (Uniprot Q5T2E6) was synthesized by GeneArt 440 (Thermofisher). c10orf76 and PI4KB (Uniprot Q9UBF8-2) were each expressed with an N-441 terminal 6xHis-tag followed by a TEV protease site. The c10orf76 and PI4KB proteins purified 442
for HDX-MS were expressed in Spodoptera frugiperda His-tagged prey protein was then added to a final concentration of 1-2 µM in a total volume of 496 50 µL, at which point 10 µL was taken for SDS-PAGE analysis. The mixture was incubated 497 on ice for an additional 30 minutes and then washed four times with 120 µL NiNTA buffer at 498 4 o C at which time an aliquot was taken as the output for SDS-PAGE analysis. 499
For GST pulldowns, Glutathione Sepharose™ 4B beads (GE healthcare) were washed 500 three times by centrifugation and resuspension in Q buffer. GST-tagged bait protein (or control 501 GST) was then added to a concentration of 3-6 µM in 50 µL and incubated with the beads on 502 ice for 10 minutes in a total volume of 50 µL. Beads were washed three times with 150 µL Q 503 buffer at 4 o C. Non-GST-tagged prey protein were then added to a final concentration of 2-4 504 µM in a total volume of 50 µL, at which point the input was taken for SDS-PAGE analysis. 505
The mixture was incubated on ice for an additional 30 minutes and then washed four times 506 with 120 µL Q buffer at 4 o C, at which time an aliquot was taken as the output for SDS-PAGE 507
analysis. 508 509
Vesicle Preparation and Lipid Kinase Assays 510
Lipid kinase assays were carried out using the Transcreener® ADP 2 FI Assay 511 (BellBrook Labs) following the published protocol as previously described [11] . In brief, 512 substrate stocks were made up containing 1.0 mg/mL PI vesicles or 4.0 mg/mL Golgi-mimetic 513 vesicles (10% PS, 20% PI, 25% PE, 45% PC) and were extruded through a 100 nm Nanosizer 514
Extruder (T&T Scientific) and then combined with in a buffer containing 20 mM Hepes pH 515 7.5, 100 mM KCl and 0.5 mM EDTA (200 µM ATP with 1.0 mg/mL PI vesicles, 20 µM ATP 516 with 1.0 mg/mL Golgi-mimetic vesicles). Kinase reactions were started by adding 2 µL of this 517 substrate stock in a 384-well black low volume plates (Corning 4514). Proteins were thawed 518 on ice and spun down to remove precipitate. Proteins were diluted individually to 4X the 519 desired concentration in Kinase Buffer (40 mM Hepes pH 7.5, 200 mM NaCl, 20 mM MgCl2, 520 0.8% Triton-X, and 0.2 mM TCEP) on ice. Proteins were then mixed together or with additional 521
Kinase buffer resulting in 2X desired concentrations of each protein. To start the reaction, 2 522 µL of 2X protein stock was added to 2 µL of 2X substrate stock in plates. After mixing, the 4 523 µL reactions consisted of 30 mM HEPES pH 7.5 (RT), 100 mM NaCl, 50 mM KCl, 10mM 524 MgCl2, 0.25 mM EDTA, 0.4% (v/v) Triton-X, 0.1 mM TCEP, 10 µM ATP and 0.5 mg/mL 525 vesicles. PI4KB was run at a final concentration of 15 nM, 20 nM or 40 nM and c10orf76 was 526 run in 4-fold curves from 1 µM -3.9 nM or 5-fold curves from 2 µM -1.6 nM. 
HDX-MS data analysis 556
Protein samples were rapidly thawed and injected onto a UPLC system kept in a cold 557 box at 2°C. The protein was run over two immobilized pepsin columns (Applied Biosystems; 558 porosyme, 2-3131-00) stored at 10°C and 2°C at 200 µL/min for 3 min and the peptides were 559 collected onto a VanGuard precolumn trap (Waters). The trap was subsequently eluted in line 560
with an Acquity 1.7 µm particle, 100 × 1 mm 2 C18 UPLC column (Waters), using a gradient 561 of 5-36% B (buffer A 0.1% formic acid, buffer B 100% acetonitrile) over 16 minutes. MS 562 experiments were performed on an Impact QTOF (Bruker) and peptide identification was done 563 by running tandem MS (MS/MS) experiments run in data-dependent acquisition mode. The 564 resulting MS/MS datasets were analyzed using PEAKS7 (PEAKS) and a false discovery rate 565 was set at 1% using a database of purified proteins and known contaminants. HD-Examiner 566 Software (Sierra Analytics) was used to automatically calculate the level of deuterium 567 incorporation into each peptide. All peptides were manually inspected for correct charge state 568 and presence of overlapping peptides. Deuteration levels were calculated using the centroid of 569 the experimental isotope clusters. Attempts at generating fully deuterated protein samples to 570 To generate E. coli expressed, PKA phosphorylated PI4KB for use in kinase assays and 589 HDX-MS, phosphorylation of Ser496 was carried out using 1.0 mg PI4KB, 20 mM MgCl2, 590 200 µM ATP and 4.2 µg PKA in NiNTA buffer, with the reaction allowed to proceed for 1 591 hour on ice. The reaction was quenched with 20 mM EDTA, and immediately loaded onto a 592 GE 1 mL HisTap FF crude to remove His-tagged PKA. Phosphorylated PI4KB was 593 concentrated followed by size exclusion chromatography as described for PI4KB above. In 594 tandem, a non-phosphorylated PI4KB control was purified in the same manner except MgCl2, 595 ATP, and PKA were not added. Protein was flash frozen in liquid N2 for storage at -80 o C. 596
HDX-MS dose response of c10orf76 of phosphorylated PI4KB 598
Phosphorylated and non-phosphorylated PI4KB were generated and purified as described 599 above. HDX reactions were conducted in 130 µl reaction volumes with a final concentration 600
Phosphorylation Analysis 610
LC-MS/MS analysis of phosphorylated variants of PI4KB was carried out as described 611 in the HDX-MS data analysis section. MS/MS datasets were analyzed using PEAKS7 to 612 identify phosphorylated peptides in PI4KB and c10orf76. A false discovery rate was set at 613 0.1% using a database of purified proteins and known contaminants. To measure PI4KB 614 phosphorylation levels using Bruker Data analysis, the phosphorylated and non-615 phosphorylated peptides of interest were extracted, and the total area of each peptide was 616 manually integrated to determine the amount of phosphorylated vs non-phosphorylated species 617 under given experimental conditions. No phosphorylation was detected in E. coli derived 618 PI4KB. For Sf9 derived PI4KB Ser294 phosphorylation, the peptides KRTAS*NPKVENEDE 619 GFP in either GFP-PI4KB or GFP-PI4KB RL494EA using a single digest with NdeI. AKAP-650 FRB-CFP, which is used to selectively recruit FKBP12-tagged proteins to the outer 651 mitochondrial membrane, has been described previously [60] . is regularly tested for Mycoplasma contamination using a commercially-available detection kit 659 (InvivoGen) and, after thawing, the cells are treated with plasmocin prophylactic (InvivoGen) 660 at 500 µg/ml for the initial three passages (6-9 days) as well as supplemented with 5 µg/ml of 661 plasmocin prophylactic for all subsequent passages. 662 according to the manufacturer's instructions. Please note that studies using the rapamycin-667 inducible protein hetero-dimerization system used a 1:2:1 ratio of plasmid DNA for 668 transfection of the FKBP12-tagged PI4KB enzyme, AKAP-FRB-CFP recruiter, and GFP-669 c10orf76 variant (total DNA: 0.4 µg/well). After 18-20 hr of transfection, cells were incubated 670 in 1 mL of modified Krebs-Ringer solution (containing 120 mM NaCl, 4.7 mM KCl, 2 mM 671 CaCl2, 0.7 mM MgSO4, 10 mM glucose, 10 mM HEPES, and adjusted to pH 7.4) and images 672 were acquired at room temperature using a Zeiss LSM 710 laser-scanning confocal microscope 673 
Replication rescue assay 693
HeLa cells were transfected with plasmids carrying WT or mutant PI4KB (RL494EA), 694
Golgi-targeting EGFP (pEGFP-GalT) or kinase-dead PI4KB (PI4KB-KD) as a negative 695 control. At 24 h post-transfection, the cells were infected with CVA10, CVB3, and PV1. At 8 696 h p.i., the infected cells were frozen, and virus titers were determined by end-point titration 697
analysis and expressed as 50% tissue culture infectious dose (TCID50). (A) PI4KB can form ternary complexes with Rab11a and c10orf76 in vitro. GST-pulldown 5 assays were carried out using GST-Rab11a(Q70L) (6 µM) or GST alone (3 µM) as the bait, 6 using 6xHis-c10orf76 (4 µM), PI4KB (2 µM) as the prey. 7 (B) PI4KB can form ternary complexes with ACBD3 and c10orf76 in vitro. GST-pulldown 8 assays were carried out using GST-ACBD3 (4 µM) or GST alone (4 µM) as the bait, and 6xHis-9 c10orf76 (3 µM) and PI4KB (2 µM) as the prey. Samples were washed a total of 4 times in all 10 experiments. 
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